Research Topics
| E C StrainSummaryAffiliation: Johns Hopkins University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-filmsE C Strain
Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
Clin Pharmacol Ther 89:443-9. 2011..There was a significant decrease in COWS scores but no significant differences between the groups. The results support the use of B and B/N soluble films as safe and effective delivery methods for opioid induction...
Drug use and sport--a commentary on: Injury, pain and prescription opioid use among former National Football League football players by Cottler et alEric C Strain
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
Drug Alcohol Depend 116:8-10. 2011....
Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusersE C Strain
Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
Psychopharmacology (Berl) 148:374-83. 2000..Non-parenteral abuse of opioids such as buprenorphine may be more likely in people who have less severe substance abuse disorders (e.g., are not physically dependent upon opioids)...- Effects of buprenorphine/naloxone in opioid-dependent humansK B Stoller
Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224, USA
Psychopharmacology (Berl) 154:230-42. 2001..Low doses of injected buprenorphine/naloxone have been tested in opioid-dependent subjects, but higher doses (more than 2 mg of either medication) and direct comparisons to SL buprenorphine/naloxone have not been examined... - Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humansS L Walsh
Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
J Pharmacol Exp Ther 299:147-58. 2001..These data suggest that these kappa-agonists may be safely administered in the presence of cocaine but do not produce significant attenuation of cocaine's direct effects or self-administration under these acute dosing conditions... - Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trialE C Strain
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
JAMA 281:1000-5. 1999..However, despite recommendations regarding effective dosing of methadone, controlled clinical trials of higher-dose methadone have not been conducted... - Gradual dose taper following chronic buprenorphineA B Becker
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Am J Addict 10:111-21. 2001..Relapse may have been triggered by a desire to re-experience the drug's positive subjective effects, craving, or low motivation to remain drug-free. A longer taper combined with an expanded range of treatments may improve prognosis... - Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humansS L Walsh
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
Psychopharmacology (Berl) 157:151-62. 2001.... - Discriminative stimulus effects of tramadol in humansAngela N Duke
Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA
J Pharmacol Exp Ther 338:255-62. 2011....